bleeding concerns about Avastin (bevacizumab)
August 2004
There are new bleeding concerns about Avastin (bevacizumab) used for metastatic colorectal cancer.
This specific topic you are searching for was not covered in the newsletter. As important new information is received, we want to provide our subscribers with it. As an extra service to our subscribers we are offering the Detail-Document.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote